Candidemia: all 73 studies

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• Middle East Study of Infections in Patients With Hematological MalignanciesRecruitingNCT07900542
• Shortening Treatment Duration in Uncomplicated Candidemia: the CanTEN TrialNot yet recruitingNCT07788586Phase 4
• A Study Comparing Short-course Antifungal Therapy (SCAT) 7 Day vs Standard 14 Day Antifungal Therapy for Uncomplicated CandidemiaNot yet recruitingNCT06907992
• A Randomized Study of a Short Duration Therapy for CandidemiaNot yet recruitingNCT06859671Phase 3
• A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.RecruitingNCT05421858Phase 3
• A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral FluconazoleTerminatedNCT05178862Phase 3Results posted
• An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida AurisCompletedNCT04148287Phase 2Results posted
• Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive CandidiasisCompletedNCT03667690Phase 3Results posted
• An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With CandidemiaCompletedNCT03604705Phase 2Results posted
• Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)CompletedNCT03363841Phase 3Results posted
• CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging ExtensionCompletedNCT02734862Phase 2Results posted
• Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive CandidiasisCompletedNCT02244606Phase 2Results posted
• Negative Beta Glucan in ICU PatientsCompletedNCT01734525Phase 4Results posted
• Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With EchinocandinsTerminatedNCT01213823Results posted
• Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United KingdomCompletedNCT01202253Results posted
• A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive CandidiasisTerminatedNCT01176058Phase 3Results posted
• A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy SubjectsCompletedNCT00940017Phase 4Results posted
• Comparison of Candida Eradication and Serum Cidal Activity of EchinocandinsCompletedNCT00839540Phase 4Results posted
• Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal CandidiasisTerminatedNCT00815516Phase 3Results posted
• An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune SystemTerminatedNCT00806351Phase 3Results posted
• An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To CandidaTerminatedNCT00805740Phase 3Results posted
• Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IVCompletedNCT00802854Results posted
• Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive CandidiasisCompletedNCT00761267Phase 3Results posted
• Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal InfectionCompletedNCT00739934Phase 2Results posted
• Anidulafungin Candidemia/Invasive Candidiasis Intensive Care StudyCompletedNCT00689338Phase 3Results posted
• β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) PatientsCompletedNCT00672841Not applicableResults posted
• This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive CandidiasisCompletedNCT00548262Phase 4Results posted
• Anidulafungin In Treatment Of Candidemia In Asian SubjectsCompletedNCT00537329Phase 3Results posted
• Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive CandidiasisCompletedNCT00496197Phase 4Results posted
• Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida InfectionsCompletedNCT00413218Phase 3Results posted
• Non-Conventional Microbiological Methods in the Diagnosis of CandidemiaCompletedNCT07422155Not applicable
• Performance Evaluation of the Fujifilm Wako Beta-D-glucan Technique in the Diagnosis of Major Invasive Fungal Infections (IFI)CompletedNCT07272915
• A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive CandidiasisCompletedNCT06194201Phase 2
• Value of PCT When Diagnosing CandidemiaCompletedNCT05385107
• Safety and Efficacy of Interferon-Gamma 1b in Patients With CandidemiaCompletedNCT04979052Phase 2
• Candida PCR Diagnosis Strategy in Patients From Intensive Care UnitsCompletedNCT04874441Not applicable
• Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow TransplantationCompletedNCT04368559Phase 3
• Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole BloodStatus unknownNCT04147975
• Echinocandins Versus Azoles for Candidemia TreatmentCompletedNCT03799172
• Dosage of Plasma 1, 3-β-D-glucan for the Diagnosis of Candidemia.Status unknownNCT03674359
• Study of Innate Host Immune Response to C. Glabrata Clinical Isolates Resistant to Echinocandins: Impact on the Management of Candidemia in High-risk PatientsStatus unknownNCT03652194
• Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE StudyCompletedNCT03174457
• Candida Host Defense Response After Septic Shock in the Critically IllCompletedNCT03136081
• Genetic Susceptibility Factors for Candidemia.CompletedNCT02841501
• Bio-assay Development and Implementation for Fungal Infection DetectionWithdrawnNCT02333266
• Serial Therapeutic and Antifungal Monitoring ProtocolCompletedNCT02163889
• Candidemia in a Pediatric Center and Importance of Central Venous Catheter RemovalCompletedNCT02088476
• A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or CandidemiaTerminatedNCT01982071Phase 4
• Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)CompletedNCT01752166
• UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer PatientsWithdrawnNCT01622595
• Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT)CompletedNCT01525095
• Anidulafungin Pharmacokinetics in Intensive Care Unit PatientsStatus unknownNCT01438216
• Early- and Late-onset CandidemiaCompletedNCT01406093
• Perception and Prevalence of Fungal Infections in Berlin - BrandenburgCompletedNCT01393002
• Study and Analysis of Micafungin for Non-albican Candidemia: Efficacy, Risk Factor and Clinical ManifestationCompletedNCT01317394
• SIHAM Candidemia Network:An Observational StudyCompletedNCT01281345
• Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of CandidemiaStatus unknownNCT01270490Phase 3
• Risk Factor and Outcome of CandidemiaStatus unknownNCT01249313
• A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)CompletedNCT01174147
• Prevalence and Epidemiology of Nosocomial Candidaemia and Antifungal Susceptibility Patterns in an Italian Tertiary-Care HospitalStatus unknownNCT00903526
• Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and ToddlersCompletedNCT00797420Phase 1
• CRITIC - Treatment of Candidemia and Invasive CandidiasisCompletedNCT00670657Phase 4
• Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the DrugCompletedNCT00608335Phase 1
• Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the DrugCompletedNCT00607763Phase 1
• A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven CandidaemiaWithdrawnNCT00509834Phase 1/2
• Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and CandidemiaCompletedNCT00189709Phase 3
• Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature InfantsCompletedNCT00113191Not applicable
• Micafungin Versus AmBisome in Invasive Candidiasis and CandidemiaCompletedNCT00106288Phase 3
• Study of Micafungin in Patients With Invasive Candidiasis or CandidemiaCompletedNCT00105144Phase 3
• The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive CandidiasisCompletedNCT00056368Phase 3
• The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.CompletedNCT00037219Phase 2
• Study of FK463 in the Treatment of Candidemia or Invasive CandidiasisCompletedNCT00036179Phase 2
• Voriconazole to Treat Fungal InfectionsCompletedNCT00001940Phase 3

← Candidemia overview